Novartis NAM SF 0,50

NOT 
(XETRA) 
 
81.67 <%= Resources.Global.txtUp %>
Updated 16:35:46
Change % 2.22% Stock price increasing
Change 1.77 Stock price increasing
Volume 16,119
High 81.88
Low 80.01
Open 80.16
ISIN CH0012005267
Prev close 79.90
# of shares 2,527.37M
Market cap 206,411M EUR
Intraday

Market closed
Novartis NAM SF 0,50
Market is closed, opens at 08:00
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  81.67 4.5% Stock price increasing 9.7% Stock price increasing -0.5% Stock price decreasing 8.7% Stock price increasing 28.1% Stock price increasing
Powered by TradingView

Related

Latest 1 week 1 month 3 months 6 months 1 year
YTD
 
Competitors Open
 
Abbott Laboratories 83.27 2.7% Stock price increasing 9.6% Stock price increasing 5.6% Stock price increasing 18.8% Stock price increasing 32.6% Stock price increasing 15.1% Stock price increasing
 
Bristol-Myers Squibb Company 48.02 2.4% Stock price increasing 2.5% Stock price increasing -3.7% Stock price decreasing -6.9% Stock price decreasing -10.5% Stock price decreasing -7.6% Stock price decreasing
 
Johnson & Johnson 140.34 0.4% Stock price increasing 1.2% Stock price increasing 2.3% Stock price increasing 7.6% Stock price increasing 15.7% Stock price increasing 8.7% Stock price increasing
 
Eli Lilly and Company 114.43 2.0% Stock price increasing -1.4% Stock price decreasing -8.6% Stock price decreasing 7.4% Stock price increasing 32.9% Stock price increasing -1.1% Stock price decreasing
 
Merck & Company Inc (new) 84.50 1.8% Stock price increasing 7.3% Stock price increasing 3.9% Stock price increasing 13.7% Stock price increasing 38.5% Stock price increasing 10.6% Stock price increasing
 
Pfizer Inc 43.21 1.3% Stock price increasing 4.2% Stock price increasing 3.3% Stock price increasing 1.9% Stock price increasing 19.5% Stock price increasing -1.0% Stock price decreasing
 
Astrazeneca PLC ORD SHS $0.25 6,401.85 4.3% Stock price increasing 9.0% Stock price increasing 0.8% Stock price increasing 7.0% Stock price increasing 18.9% Stock price increasing 9.0% Stock price increasing
 
Roche Hldg AG GEN 249.65 2.3% Stock price increasing 5.4% Stock price increasing 4.1% Stock price increasing 13.7% Stock price increasing 38.6% Stock price increasing 15.8% Stock price increasing
 
Glaxosmithkline PLC ORD 25P 1,595.20 1.4% Stock price increasing 2.6% Stock price increasing 5.5% Stock price increasing 10.2% Stock price increasing 2.7% Stock price increasing 7.0% Stock price increasing
 
Dr Reddy's Laboratories Ltd 37.32 -1.6% Stock price decreasing -5.2% Stock price decreasing -4.5% Stock price decreasing 0.0% Stock price unchanged 6.6% Stock price increasing -1.0% Stock price decreasing
 
Sanofi 77.47 1.8% Stock price increasing 3.0% Stock price increasing -2.2% Stock price decreasing 1.7% Stock price increasing 13.5% Stock price increasing 2.4% Stock price increasing

Company profile

Novartis AG develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total sales.

Peers

Instruments Last Change  
Abbott Labor.. 83.27 1.5% Stock price increasing
Bristol-Myer.. 48.02 -0.4% Stock price decreasing
Johnson & Jo.. 140.34 0.6% Stock price increasing
Eli Lilly an.. 114.43 0.9% Stock price increasing
Merck & Comp.. 84.50 1.4% Stock price increasing
Pfizer Inc 43.21 0.8% Stock price increasing
Astrazeneca .. 6,401.85 2.4% Stock price increasing
Roche Hldg A.. 249.65 1.0% Stock price increasing
Glaxosmithkl.. 1,595.20 0.4% Stock price increasing
Dr Reddy's L.. 37.32 3.0% Stock price increasing
Sanofi 77.47 2.7% Stock price increasing

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
18 June 2019 20:37:05
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190527.1 - EUROWEB7 - 2019-06-18 21:37:05 - 2019-06-18 20:37:05 - 1000 - Website: OKAY